The radiopharmaceutical market analysis report forecasts that the market will reach US$21.14 billion in 2032. Radiopharmaceuticals are widely used, from diagnostics to cancer treatment.
According to the Radiopharmaceutical Market Analysis Report (2026), the market is forecast to reach US$21.14 billion in 2032. The market is expected to encompass a broad range of products, from diagnostic to therapeutic applications.
Radiopharmaceuticals are medicines containing radioactive isotopes that are used to diagnose and treat diseases, and are used in combination with diagnostic imaging technologies such as PET.